We showed recently18 that the APOBEC mutation signature is a poor predictor of APOBEC3A/B expression in tumors, because while APOBEC mutations are a permanent record in a cancer cell’s genome, APOBEC expression can be transient, returning to baseline after mutagenic episodes4. Here, APOBEC3A is linked to cancer.